Springer J, Cauch-Dudek K, O'Rourke K, Wanless I R, Heathcote E J
Department of Medicine, The Toronto Hospital, University of Toronto, Ontario, Canada.
Am J Gastroenterol. 1999 Jan;94(1):47-53. doi: 10.1111/j.1572-0241.1999.00770.x.
To document the natural history of asymptomatic primary biliary cirrhosis and identify prognostic features that would predict the development of symptomatic disease.
A retrospective chart review of all patients with abnormal liver biochemical tests and antimitochondrial antibody-positive, liver biopsy-compatible primary biliary cirrhosis who were seen in a single tertiary care center between 1983 and 1994 was performed. Statistical analysis using Cox regression was employed to compare survival of the study population with an age- and gender-matched control population and to identify potential prognostic variables.
Ninety-one patients were included. Median age at presentation was 53.2 yr. Ninety percent were female. Median follow up was 61.2 months (range 7-206 months). Thirty-six percent (33 patients) became symptomatic with 11% (10 patients) progressing to death or liver transplant. Median predicted length of survival from onset of disease for the entire cohort was 14 yr. Patient survival was less than that predicted for an age- and gender-matched control population (p < 0.05). Univariate and multivariate analysis on a broad spectrum of clinical, biochemical, and histological features at the time of initial presentation failed to reveal any prognostic variables that would distinguish those who would become symptomatic from those who would remain symptom-free. Specifically, three primary variables of interest (associated autoimmune disorders, hepatomegaly, and histological stage) were not found to predict prognosis.
Patients who present with asymptomatic primary biliary cirrhosis have a shorter life span than the general population. Presently, there are no prognostic features that identify the patients who will develop progressive disease from those who will remain symptom-free. Therefore, treatment should be offered to all patients.
记录无症状原发性胆汁性肝硬化的自然病程,并确定可预测症状性疾病发生的预后特征。
对1983年至1994年间在单一三级医疗中心就诊的所有肝生化检查异常且抗线粒体抗体阳性、肝活检符合原发性胆汁性肝硬化的患者进行回顾性病历审查。采用Cox回归进行统计分析,以比较研究人群与年龄和性别匹配的对照人群的生存率,并确定潜在的预后变量。
纳入91例患者。就诊时的中位年龄为53.2岁。90%为女性。中位随访时间为61.2个月(范围7 - 206个月)。36%(33例患者)出现症状,11%(10例患者)进展至死亡或肝移植。整个队列从疾病发作起的中位预测生存时长为14年。患者生存率低于年龄和性别匹配的对照人群(p < 0.05)。对初始就诊时广泛的临床、生化和组织学特征进行单因素和多因素分析,未能揭示任何可区分出现症状者与无症状者的预后变量。具体而言,未发现三个感兴趣的主要变量(相关自身免疫性疾病、肝肿大和组织学分期)可预测预后。
出现无症状原发性胆汁性肝硬化的患者寿命比一般人群短。目前,尚无预后特征可识别哪些患者会发展为进展性疾病,哪些患者将保持无症状。因此,应向所有患者提供治疗。